Dr. Riley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
125 Paterson St
Clinical Academic Building - Suite 5200b
New Brunswick, NJ 08901Phone+1 732-235-6511Fax+1 732-235-7048
Education & Training
- Johns Hopkins UniversityResidency, Internal Medicine, 1972 - 1973
- University of Pennsylvania Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 1970 - 1972
- Johns Hopkins University/Bayview Medical CenterResidency, Internal Medicine, 1968 - 1970
- University of Maryland School of MedicineClass of 1968
Certifications & Licensure
- NJ State Medical License 1973 - 2015
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Publications & Presentations
PubMed
- 501 citationsMycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trialDonald P. Tashkin, Michael D. Roth, Philip J. Clements, Daniel E. Furst, Dinesh Khanna
The Lancet. Respiratory Medicine. 2016-09-01 - 23 citationsBeta-Aminopropionitrile Prevents Bleomycin-induced Pulmonary Fibrosis in the Hamster1–3David J. Riley, Janet S. Kerr, Richard A. Berg, Barbara D. Ianni, Giuseppe G. Pietra
The American Review of Respiratory Disease. 2015-05-14 - 10 citationsDegradation of Collagen in Lung Tissue Slices Exposed to Hyperoxia1–3Janet S. Kerr, Claudia U. Chae, Hideaki Nagase, Richard A. Berg, David J. Riley
The American Review of Respiratory Disease. 2015-05-14
Grant Support
- Scleroderma Lung StudyNational Heart, Lung, And Blood Institute1999–2003
- Oral Cyclophosphamide VS Oral Placebo In SSC AlveolitisNational Heart, Lung, And Blood Institute2000
- Cells And Extracellular Matrix In Pulmonary HypertensionNational Heart, Lung, And Blood Institute1987–1995
- Respiratory BiologyNational Heart, Lung, And Blood Institute1990–1994
- Familial Pulmonary FibrosisNational Heart, Lung, And Blood Institute1990–1992
- Prevention Of Lung Injury By A Proline AnalogueNational Heart, Lung, And Blood Institute1985–1986
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: